ALLO

ALLO Financing Cash Flow

$220.09MTTM · USD

Period ending:

ALLO FY Cash from FinancingUSD
ALLO FY Cash from Financing2017-12-31: $0.002018-12-31: $771.18M2019-12-31: $58.96M2020-12-31: $633.59M2021-12-31: $11.96M2022-12-31: $2.95M2023-12-31: $95.70M2024-12-31: $116.68M2025-12-31: $30.16M$771.18M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ALLO financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Allogene Therapeutics Inc Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
30,157,000
116,675,000
95,695,000
2,950,000
11,963,000
633,591,000
58,960,000
771,182,000
0

Compare financing cash flow

All ALLO financial metrics · ALLO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.